Supplement: VA HB820 | 2024 | Regular Session | House: Prefiled and ordered printed; offered 01/10/24 24101288D

For additional supplements on Virginia HB820 please see the Bill Drafting List
Bill Title: Sickle cell disease; annual review of medication and treatment, report.

Status: 2024-04-02 - Governor: Acts of Assembly Chapter text (CHAP0306) [HB820 Detail]

Download: Virginia-2024-HB820-House_Prefiled_and_ordered_printed_offered_01-10-24_24101288D.pdf
It appears your computer is unable to display this document, however you can Download Virginia-2024-HB820-House_Prefiled_and_ordered_printed_offered_01-10-24_24101288D.pdf here.

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

OH HB79 Permit electric distribution utility establish certain portfolios
PA HB2530 Further providing for hazardous air pollutants.
CA AB661 Utility services: electronic communication.
NH HB1492 Relative to the rate and exemptions of the interest and dividends tax.
IL SB3314 CONSUMER LEGAL-REFINANCING
CA AB3004 Proposition 65: certificates of merit: Attorney General communications...
CA AB2257 Local government: property-related water and sewer fees and assessments:...
CA AB2054 Energy: employment, gifts, and rates.
CA SB1141 Mediation: amount in controversy.
NH HB1259 Relative to property and casualty insurance laws administered by the insurance...
feedback